| 1 |
34074311 | PS-341 alleviates chronic low-grade inflammation and improves insulin sensitivity through the inhibition of TM4 (UBAC2) degradation. | 2021 Jun 1 |
1 |
| 2 |
31239273 | Sphingosine Kinase 1 Signaling Promotes Metastasis of Triple-Negative Breast Cancer. | 2019 Aug 15 |
1 |
| 3 |
30487672 | Ameliorating effects of bortezomib, a proteasome inhibitor, on development of dextran sulfate sodium-induced murine colitis. | 2018 Nov |
1 |
| 4 |
28487944 | Bortezomib protects against dextran sulfate sodium‑induced ulcerative colitis in mice. | 2017 Jun |
2 |
| 5 |
27211850 | Inhibition of the neuronal NFκB pathway attenuates bortezomib-induced neuropathy in a mouse model. | 2016 Jul |
9 |
| 6 |
25653480 | Proteasome inhibitor bortezomib suppresses nuclear factor-kappa B activation and ameliorates eye inflammation in experimental autoimmune uveitis. | 2015 |
2 |
| 7 |
25712341 | FOXP3-miR-146-NF-κB Axis and Therapy for Precancerous Lesions in Prostate. | 2015 Apr 15 |
1 |
| 8 |
26191178 | Bortezomib inhibits bone marrow-derived dendritic cells. | 2015 |
2 |
| 9 |
24301524 | Proteasome inhibitors exert cytotoxicity and increase chemosensitivity via transcriptional repression of Notch1 in T-cell acute lymphoblastic leukemia. | 2014 Jun |
3 |
| 10 |
24504138 | Thymoquinone overcomes chemoresistance and enhances the anticancer effects of bortezomib through abrogation of NF-κB regulated gene products in multiple myeloma xenograft mouse model. | 2014 Feb 15 |
1 |
| 11 |
25505605 | Azithromycin inhibits nuclear factor-κB activation during lung inflammation: an in vivo imaging study. | 2014 Oct |
2 |
| 12 |
22287559 | Opposing effects of bortezomib-induced nuclear factor-κB inhibition on chemical lung carcinogenesis. | 2012 Apr |
1 |
| 13 |
21785822 | Anti-tumor activity of the proteasome inhibitor bortezomib in gastric cancer. | 2011 Dec |
1 |
| 14 |
19940859 | NF-kappaB inhibition through proteasome inhibition or IKKbeta blockade increases the susceptibility of melanoma cells to cytostatic treatment through distinct pathways. | 2010 Apr |
1 |
| 15 |
20372109 | Detrimental effect of the proteasome inhibitor, bortezomib in bacterial superantigen- and lipopolysaccharide-induced systemic inflammation. | 2010 Jun |
3 |
| 16 |
20886569 | Anti-tumor necrosis factor α treatment promotes apoptosis and prevents liver regeneration in a transgenic mouse model of chronic hepatitis C. | 2010 Nov |
1 |
| 17 |
19054826 | Bortezomib attenuates murine collagen-induced arthritis. | 2009 Nov |
2 |
| 18 |
19843184 | NF-kappaB regulates the transcription of protein tyrosine kinase Tec. | 2009 Nov |
1 |
| 19 |
18489772 | Prevalence of bortezomib-resistant constitutive NF-kappaB activity in mantle cell lymphoma. | 2008 May 19 |
5 |
| 20 |
17346202 | Use of systemic proteasome inhibition as an immune-modulating agent in disease. | 2007 Mar |
1 |
| 21 |
16174760 | NF-kappaB as a target for the prevention of graft-versus-host disease: comparative efficacy of bortezomib and PS-1145. | 2006 Jan 15 |
1 |
| 22 |
16585569 | Immunosensitization of tumor cells to dendritic cell-activated immune responses with the proteasome inhibitor bortezomib (PS-341, Velcade). | 2006 Apr 15 |
2 |
| 23 |
15797874 | NF-kappaB and not the MAPK signaling pathway regulates GADD45beta expression during acute inflammation. | 2005 Jun 3 |
1 |
| 24 |
15090453 | Effects of the proteasome inhibitor PS-341 on tumor growth in HTLV-1 Tax transgenic mice and Tax tumor transplants. | 2004 Aug 1 |
1 |
| 25 |
11350913 | Novel proteasome inhibitor PS-341 inhibits activation of nuclear factor-kappa B, cell survival, tumor growth, and angiogenesis in squamous cell carcinoma. | 2001 May |
6 |